Cargando…
The Role of Fluoroquinolones in the Treatment of Tuberculosis in 2019
The inability to use powerful antituberculosis drugs in an increasing number of patients seems to be the biggest threat towards global tuberculosis (TB) elimination. Simplified, shorter and preferably less toxic drug regimens are being investigated for pulmonary TB to counteract emergence of drug re...
Autores principales: | Pranger, A. D., van der Werf, T. S., Kosterink, J. G. W., Alffenaar, J. W. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373389/ https://www.ncbi.nlm.nih.gov/pubmed/30617959 http://dx.doi.org/10.1007/s40265-018-1043-y |
Ejemplares similares
-
Pharmacokinetic Drug Interactions of Antimicrobial Drugs: A Systematic Review on Oxazolidinones, Rifamycines, Macrolides, Fluoroquinolones, and Beta-Lactams
por: Bolhuis, Mathieu S., et al.
Publicado: (2011) -
Predictors of Prolonged TB Treatment in a Dutch Outpatient Setting
por: van’t Boveneind-Vrubleuskaya, Natasha, et al.
Publicado: (2016) -
Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones
por: Migliori, Giovanni Battista, et al.
Publicado: (2012) -
Optimal Sampling Strategies for Therapeutic Drug Monitoring of First-Line Tuberculosis Drugs in Patients with Tuberculosis
por: Saktiawati, Antonia Morita I., et al.
Publicado: (2019) -
Treatment outcomes of patients with MDR-TB in Nepal on a current programmatic standardised regimen: retrospective single-centre study
por: Ghimire, Samiksha, et al.
Publicado: (2020)